136 related articles for article (PubMed ID: 1309779)
21. Purification and characterization of human papillomavirus type 16 E7 protein with preferential binding capacity to the underphosphorylated form of retinoblastoma gene product.
Imai Y; Matsushima Y; Sugimura T; Terada M
J Virol; 1991 Sep; 65(9):4966-72. PubMed ID: 1870208
[TBL] [Abstract][Full Text] [Related]
22. Determination of the binding affinity of different human papillomavirus E7 proteins for the tumour suppressor pRb by a plate-binding assay.
Dong WL; Caldeira S; Sehr P; Pawlita M; Tommasino M
J Virol Methods; 2001 Oct; 98(1):91-8. PubMed ID: 11543887
[TBL] [Abstract][Full Text] [Related]
23. Comparison of the properties of the E6 and E7 genes of low- and high-risk cutaneous papillomaviruses reveals strongly transforming and high Rb-binding activity for the E7 protein of the low-risk human papillomavirus type 1.
Schmitt A; Harry JB; Rapp B; Wettstein FO; Iftner T
J Virol; 1994 Nov; 68(11):7051-9. PubMed ID: 7933087
[TBL] [Abstract][Full Text] [Related]
24. Papillomavirus E7 protein binding to the retinoblastoma protein is not required for viral induction of warts.
Defeo-Jones D; Vuocolo GA; Haskell KM; Hanobik MG; Kiefer DM; McAvoy EM; Ivey-Hoyle M; Brandsma JL; Oliff A; Jones RE
J Virol; 1993 Feb; 67(2):716-25. PubMed ID: 8380462
[TBL] [Abstract][Full Text] [Related]
25. Human papillomavirus type 18 E7 protein requires intact Cys-X-X-Cys motifs for zinc binding, dimerization, and transformation but not for Rb binding.
McIntyre MC; Frattini MG; Grossman SR; Laimins LA
J Virol; 1993 Jun; 67(6):3142-50. PubMed ID: 8497045
[TBL] [Abstract][Full Text] [Related]
26. Altered cell cycle regulation in the lens of HPV-16 E6 or E7 transgenic mice: implications for tumor suppressor gene function in development.
Pan H; Griep AE
Genes Dev; 1994 Jun; 8(11):1285-99. PubMed ID: 7926731
[TBL] [Abstract][Full Text] [Related]
27. Inactivation of both the retinoblastoma tumor suppressor and p21 by the human papillomavirus type 16 E7 oncoprotein is necessary to inhibit cell cycle arrest in human epithelial cells.
Helt AM; Funk JO; Galloway DA
J Virol; 2002 Oct; 76(20):10559-68. PubMed ID: 12239337
[TBL] [Abstract][Full Text] [Related]
28. The human papillomavirus type 16 E7 protein complements adenovirus type 5 E1A amino-terminus-dependent transactivation of adenovirus type 5 early genes and increases ATF and Oct-1 DNA binding activity.
Wong HK; Ziff EB
J Virol; 1996 Jan; 70(1):332-40. PubMed ID: 8523545
[TBL] [Abstract][Full Text] [Related]
29. The HPV-16 E7 oncoprotein binds Skip and suppresses its transcriptional activity.
Prathapam T; Kühne C; Banks L
Oncogene; 2001 Nov; 20(52):7677-85. PubMed ID: 11753645
[TBL] [Abstract][Full Text] [Related]
30. Molecular mechanisms of transformation by the human papillomaviruses.
Howley PM; Münger K; Werness BA; Phelps WC; Schlegel R
Princess Takamatsu Symp; 1989; 20():199-206. PubMed ID: 2562182
[TBL] [Abstract][Full Text] [Related]
31. Single amino acid substitutions in "low-risk" human papillomavirus (HPV) type 6 E7 protein enhance features characteristic of the "high-risk" HPV E7 oncoproteins.
Sang BC; Barbosa MS
Proc Natl Acad Sci U S A; 1992 Sep; 89(17):8063-7. PubMed ID: 1325643
[TBL] [Abstract][Full Text] [Related]
32. The high-risk HPV oncogene E7 upregulates miR-182 expression through the TGF-β/Smad pathway in cervical cancer.
Chen J; Deng Y; Ao L; Song Y; Xu Y; Wang CC; Choy KW; Tony Chung KH; Du Q; Sui Y; Yang T; Yang J; Li H; Zou C; Tang T
Cancer Lett; 2019 Sep; 460():75-85. PubMed ID: 31247272
[TBL] [Abstract][Full Text] [Related]
33. Human papillomavirus type 16 E7 maintains elevated levels of the cdc25A tyrosine phosphatase during deregulation of cell cycle arrest.
Nguyen DX; Westbrook TF; McCance DJ
J Virol; 2002 Jan; 76(2):619-32. PubMed ID: 11752153
[TBL] [Abstract][Full Text] [Related]
34. SOCS1 [corrected] inhibits HPV-E7-mediated transformation by inducing degradation of E7 protein.
Kamio M; Yoshida T; Ogata H; Douchi T; Nagata Y; Inoue M; Hasegawa M; Yonemitsu Y; Yoshimura A
Oncogene; 2004 Apr; 23(17):3107-15. PubMed ID: 15021916
[TBL] [Abstract][Full Text] [Related]
35. Interactions of human papillomavirus transforming proteins with the products of tumor suppressor genes.
Vousden K
FASEB J; 1993 Jul; 7(10):872-9. PubMed ID: 8393818
[TBL] [Abstract][Full Text] [Related]
36. Targeting mechanism of the retinoblastoma tumor suppressor by a prototypical viral oncoprotein. Structural modularity, intrinsic disorder and phosphorylation of human papillomavirus E7.
Chemes LB; Sánchez IE; Smal C; de Prat-Gay G
FEBS J; 2010 Feb; 277(4):973-88. PubMed ID: 20088881
[TBL] [Abstract][Full Text] [Related]
37. Adenovirus E1A, simian virus 40 tumor antigen, and human papillomavirus E7 protein share the capacity to disrupt the interaction between transcription factor E2F and the retinoblastoma gene product.
Chellappan S; Kraus VB; Kroger B; Munger K; Howley PM; Phelps WC; Nevins JR
Proc Natl Acad Sci U S A; 1992 May; 89(10):4549-53. PubMed ID: 1316611
[TBL] [Abstract][Full Text] [Related]
38. Destabilization of the RB tumor suppressor protein and stabilization of p53 contribute to HPV type 16 E7-induced apoptosis.
Jones DL; Thompson DA; Münger K
Virology; 1997 Dec; 239(1):97-107. PubMed ID: 9426450
[TBL] [Abstract][Full Text] [Related]
39. Trans-activation of the adenovirus E2 promoter by human papillomavirus type 16 E7 is mediated by retinoblastoma-dependent and -independent pathways.
Carlotti F; Crawford L
J Gen Virol; 1993 Nov; 74 ( Pt 11)():2479-86. PubMed ID: 8245866
[TBL] [Abstract][Full Text] [Related]
40. Structure of the retinoblastoma tumour-suppressor pocket domain bound to a peptide from HPV E7.
Lee JO; Russo AA; Pavletich NP
Nature; 1998 Feb; 391(6670):859-65. PubMed ID: 9495340
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
